Letrozole study for uterine fibroids
Treatments studied
Part of Cancer clinical trials.
This trial tests if the drug letrozole can improve symptoms like heavy bleeding and pelvic pain caused by uterine fibroids. You must be premenopausal with moderate to severe symptoms and not have very large fibroids or certain other conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 21 and 54 years old, still having periods.
- You have uterine fibroids seen on an ultrasound or MRI in the last 2 years.
- You have symptoms like heavy bleeding, pelvic pressure, or pain for at least 3 months.
- You agree to use a non-hormonal birth control method (like a copper IUD) during the study.
- You do not have fibroids larger than 10 cm or a uterus larger than 16 cm long.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called terlipressin, which may help reduce bleeding during surgery to remove uterine fibroids. If you are having fibroid surgery, this study may help make your surgery safer with less blood loss.
This study looks at how aging cells in the uterus may cause fibroids. Researchers will collect tissue and blood samples to understand fibroid growth better.
This trial tests two supplements (Elix Cycle Balance and Elix Daily Harmony) to see if they can reduce pain and other symptoms caused by uterine fibroids. It is for women who have regular but painful periods and want to try a non-medicine option.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This Phase 2 trial studies whether letrozole can help prevent uterine leiomyosarcoma from coming back after surgery. It focuses on people whose tumor shows estrogen receptor positivity.
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
Hear when a new Leiomyoma, Uterine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.